Peers discussed margin pressure and cost volatility, while Marty Makary served as a high-profile expert on policy issues.
1 report, 1 independent
Updated Sep 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Peers discussed margin pressure and cost volatility, while Marty Makary served as a high-profile expert on policy issues.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Dignity Health
US not-for-profit healthcare system
-
Emory Healthcare
American health care system
Nothing else this week.
-
Marty Makary
American surgeon and FDA Commissioner
Nothing else this week.